Thank you for the opportunity. Can you just share your thoughts on the demand-supply scenario in the Pyridine side and the possible reasons for muted pricing there?
Yes. So, this 30% to 40% utilization of the Chinese facilities, right, is there any change in that? Or the price - like the question was that is there a reason for the muted pricing? Or you expect any changes in the pricing scenario?